Clinical Trial Update: Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of HDM1002 tablets in Chinese adults who are overweight or obese; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HDM1002 (HDM1002)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Overweight and Obesity | Phase 3 | Status: NOT_YET_RECRUITING